Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Cullman AL, Macon GA, Columbia SC, Charlotte NC,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Cullman AL, Stockbridge GA, Macon GA, Columbia SC,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase 3, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Cullman AL, Atlanta GA, Stockbridge GA, Macon GA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase 2, Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Minds Navigating the Diagnosis of Mild Cognitive Impairment
for
Cognitive Dysfunction, Mild Cognitive Impairment
Location: Tuscaloosa AL, Salem VA
Sponsor: Tuscaloosa Research & Education Advancement Corporation
Sex: All
Age: 60+
Code: NCT05690243
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Cullman AL, Bradenton FL, Maplewood MN
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07881757
Phase 3, Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
for
Excessive Sleepiness, Shift-work Disorder
Location: Cullman AL, Auburn AL, Atlanta GA, Stockbridge GA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06568367
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Cullman AL, Anniston AL, Atlanta GA, Stockbridge GA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Cullman AL, Little Rock AR, Bradenton FL, Dallas TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07823608
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cullman AL, Atlanta GA, Decatur GA, Cordele GA,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase 3, Recruiting
Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19